Eumovate^® (Clobetasone Butyrate 0.05% Cream and Ointment)

  Content:

EFFICACY

• Clobetasone butyrate 0.05% cream with its moisturizing emollient base is reported to provide better healing properties than hydrocortisone 1% cream. Its high glycerol content promotes skin hydration and protects and moisturizes the skin.

[J Dermatol Treat. 2001 Dec;12(4):191-7.]

• has no demonstrated potential for skin thinning vs. 1% hydrocortisone.

[GSK product monograph]

• has negligible systemic absorption and effect on HOP axis function.

[GSK product monograph]

• has minimal side effects even in children under 2.

[GSK product monograph]

• has a high glycerol content which promotes skin hydration and absorption.

[J Dermatol Treat. 2001 Dec; 12(4):191-7.]

• contains dimethicone to protect and moisturize the skin.

[J Dermatol Treat. 2001 Dec; 12(4):191-7.]

• The emollient base used for Eumovate® cream offers better healing properties than 1% hydrocortisone.

[J Dermatol Treat. 2001 Dec; 12(4):191-7.]

Next:   Compliance